Organon & Co. (OGN)
9.76
+0.43
(+4.61%)
USD |
NYSE |
Apr 17, 16:00
9.72
-0.04
(-0.41%)
Pre-Market: 20:00
Organon Free Cash Flow : 508.00M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Abbott Laboratories | 7.395B |
| Gilead Sciences, Inc. | 9.456B |
| Pfizer Inc. | 9.076B |
| Replimune Group, Inc. | -283.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 141.00M |
| Cash from Investing (Quarterly) | -65.00M |
| Cash from Financing (Quarterly) | -187.00M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 228.00M |
| Free Cash Flow to Firm (Quarterly) | 370.37M |
| Free Cash Flow Yield | 19.98% |